CMOS Study
Applied Cannabis Research » CMOS Study
Welcome to the CMOS Study
The CMOS study, is Australia’s largest medicinal Cannabis study. The CMOS study has a target of 20,000 patients over a 5 year period.
This study aims to collect important real-world data about safety and efficacy of medicinal cannabis products in the treatment of refractory indications, as well as data on effective dosage and effects of medicinal cannabis treatment on concomitant medication use.
- Help Advance Medical Research
- Simple Enrolment and Participation
- Access to a Research and Prescribing Support Team
- Access to Interim CMOS Study Data